Cargando…
A Case of Concurrent Leukocytosis and Systemic Capillary Leak Syndrome Due to Pegfilgrastim
Pegfilgrastim is a granulocyte colony-stimulating factor agent used in patients receiving myelosuppressive therapy with chemotherapy or radiation. Two adverse effects associated with this agent include capillary leak syndrome and leukocytosis. To our knowledge, this is the first case of a patient wh...
Autores principales: | Gotera, Nico, Hasan, Shayee, Shrestha, Pritee, Heleno, Caio, Tesar, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156363/ https://www.ncbi.nlm.nih.gov/pubmed/35663724 http://dx.doi.org/10.7759/cureus.24640 |
Ejemplares similares
-
Leukocytosis and Spurious Hypoxemia
por: Gupta, Sachin, et al.
Publicado: (2021) -
Etiologies of Extreme Leukocytosis
por: Viner, Esther, et al.
Publicado: (2023) -
Myasthenia Gravis as an Immune-Mediated Side Effect of Checkpoint Inhibitors
por: Heleno, Caio T, et al.
Publicado: (2021) -
Capillary Leak Syndrome Aggravated by Influenza Type A Infection
por: Lawrence, James L, et al.
Publicado: (2018) -
Systemic Capillary Leak Syndrome (SCLS) Presentation in Patients Receiving Anti-cancer Treatments
por: Anipindi, Manasa, et al.
Publicado: (2023)